LDS/Medical Tests/Acute Hepatitis Panel

Acute Hepatitis Panel

This test panel is Medicare approved for diagnosis of acute hepatitis. It includes these components:

Hepatitis A antibody, IgM (HAAb) Hepatitis A is caused by infection with the hepatitis A virus (HAV) and is the most common cause of hepatitis in North America. Transmission of Hepatitis A virus is via the fecal-oral route, and infection occurs mainly due to contaminated food or poor sanitary conditions. Outbreaks regularly occur where there are large groups of people, such as schools and prisons. The average incubation period for Hepatitis A virus infection is 30 days with symptoms usually occurring between 15 and 45 days after infection. Symptoms last approximately 2 weeks and include hepatomegaly, jaundice, dark urine, fatigue, and gastrointestinal distress such as anorexia, nausea, vomiting, and abdominal pain.

Hepatitis A IgM is detectable. Anti-HAV IgG usually appears quickly once the virus is eliminated. Anti-HAV IgM is detectable for 3 to 6 months after the onset of illness, whereas anti-HAV IgG can persist indefinitely. The specific determination of anti-HAV IgM is the most useful serological marker for diagnosing acute HAV infection. Total anti-HAV is used primarily for determination of previous exposure or immunity to Hepatitis A virus by vaccination.

Hepatitis B core antibody, IgM (HBcAb) Hepatitis B infection is caused by the Hepatitis B Virus. Hepatitis B virus is spread by contact with contaminated blood and body fluids. Chronic infection with Hepatitis B virus results in damage to the liver, ultimately resulting in liver disease including cirrhosis and/or liver cancer. The body’s immune system is responsible for the liver tissue damage because it destroys the liver cells containing the virus.

Hepatitis B core antibody is the most commonly detected antibody in the disease. Total Anti-HBc antibody testing includes IgG and IgM to HBc antigen. Total Anti-HBc will be positive indefinitely, whereas IgM is usually positive for 3 to 6 months after acute viral infection. HBc IgM assays should not be used to test for acute Hepatitis B virus infection.

Hepatitis B surface antigen (HBsAg) Hepatitis B infection is caused by the Hepatitis B Virus. Hepatitis B virus is spread by contact with contaminated blood and body fluids. Chronic infection with Hepatitis B virus results in damage to the liver, cirrhosis and/or liver cancer. The body’s immune system is responsible for the liver tissue damage because it destroys the liver cells containing the virus. In hepatitis B virus infection, surface antigen is detectable 2-5 weeks before onset of symptoms, rises in titer, and peaks at about the time of onset of clinical illness. Generally, it persists for 1-5 months, declining in titer and disappearing with resolution of clinical symptoms. HBsAg is a first-line test for the diagnosis of acute or chronic hepatitis B. HBsAg is an indicator for active infection. It is a marker used for detecting initial infection, monitoring the course of the infection and progression to chronic disease. It is also used in the screening of donor blood.

Hepatitis C antibody The hepatitis C virus or HCV is an infectious virus that affects the liver. HCV is a bloodborne virus and is transmitted in various manners, including sexual contact, blood to blood contact, sharing drug needles, and before 1990, through blood or blood product transfusion. HCV infected patients have a higher risk of liver cirrhosis and liver cancer. Symptoms of infection are fatigue, abdominal discomfort, loss of appetite and flu-like symptoms; however, the majority of patients infected with the hepatitis C virus have little to no warning symptoms, especially in the acute phase. The HCV infection if left untreated will develop into acute phase hepatitis, which is typically within the first six months following primary infection. Most diagnosis of chronic hepatitis is made accidentally when routine laboratory tests are performed. Liver enzymes may be slightly elevated at this point. Serological hepatitis testing is important in diagnosing patients and protecting blood recipients from infected blood products. Hepatitis C antibody testing, when positive, is confirmed by HCV PCR to determine if the infection is in active status.

  • Diagnosis of acute infectious hepatitis
  • Diagnosis of acute hepatitis A disease
  • Diagnosis of acute hepatitis B disease
  • Diagnosis of acute hepatitis C disease

Positive in:

  • Hepatitis A
  • Hepatitis B
  • Hepatitis C

Not detected (Negative)

Chemiluminescent Immunoassay, ELISA

Serum (SST tube).

Stability

  • Ambient: 2-3 days
  • Refrigerated: 7 days
Hepatitis C by PCR (viral load), Hepatitis Be antigen, Hepatitis B by PCR (viral load), Hepatitis functional profile, Hepatitis D Virus Ab.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login